Zobrazeno 1 - 6
of 6
pro vyhledávání: '"José Sullivan López González"'
Autor:
Olga N. Hernández de la Cruz, José Sullivan López-González, Raúl García-Vázquez, Yarely M. Salinas-Vera, Marcos A. Muñiz-Lino, Dolores Aguilar-Cazares, César López-Camarillo, Ángeles Carlos-Reyes
Publikováno v:
Frontiers in Oncology, Vol 9 (2020)
Vasculogenic mimicry (VM) is a mechanism whereby cancer cells form microvascular structures similar to three-dimensional channels to provide nutrients and oxygen to tumors. Unlike angiogenesis, VM is characterized by the development of new patterned
Externí odkaz:
https://doaj.org/article/f731450ae3df4f04807b213906b1b52c
Autor:
Ángeles Carlos-Reyes, José Sullivan López-González, Manuel Meneses-Flores, Dolores Gallardo-Rincón, Erika Ruíz-García, Laurence A. Marchat, Horacio Astudillo-de la Vega, Olga N. Hernández de la Cruz, César López-Camarillo
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Epigenetic mechanisms control gene expression during normal development and their aberrant regulation may lead to human diseases including cancer. Natural phytochemicals can largely modulate mammalian epigenome through regulation of mechanisms and pr
Externí odkaz:
https://doaj.org/article/04eb6cd1265e490baca7591ef16a1b65
Autor:
Maribel Soto-Núñez, Karen Azucena Díaz-Morales, Patricia Cuautle-Rodríguez, Víctor Torres-Flores, José Sullivan López-González, Juan José Mandoki Witzner, Juan Arcadio Molina-Guarneros
Publikováno v:
Current Overview on Pharmaceutical Science Vol. 7 ISBN: 9788119039975
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e236b52f286bf69c919b8df8e437971
https://doi.org/10.9734/bpi/cops/v7/4352c
https://doi.org/10.9734/bpi/cops/v7/4352c
Autor:
Carlos Pérez Plasencia, Frederik García‑García, Erika Ruiz Garcia, César López‑Camarillo, José Sullivan López‑González, Maribel Aguilar‑Medina, Sergio Cuevas, Yarely M. Salinas‑Vera, Raúl García‑Vázquez, Ángeles Carlos‑Reyes, Laurence A. Marchat, Rosalio Ramos Payan
Publikováno v:
Oncology Reports.
Cancer patients who better benefit from neoadjuvant chemotherapy (NeoCh) are those who achieve a successful pathological complete response (pCR) represented by the absence of residual disease. Unfortunately, no highly sensitive and specific tumor bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024a5fff31dbe57fed6c844c7787df1e
https://doi.org/10.3892/or.2019.7102
https://doi.org/10.3892/or.2019.7102
Autor:
José Sullivan López González, Renata Alejandra Báez Saldaña, Lorenzo Islas Vázquez, Uriel Rumbo Nava
Publikováno v:
11.1 Lung Cancer.
Lung cancer is the leading cause of cancer death in both genders and the second leading cause of new cases of cancer. The median survival of patients in advanced stages is 6-13 months. Some antineoplastic agents induce the killing of tumor cells, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e27af6d12442ddf5329697e76b264dc9
https://doi.org/10.1183/13993003.congress-2016.pa517
https://doi.org/10.1183/13993003.congress-2016.pa517
Autor:
Verónica, Rojo-León, Dolores, Aguilar-Cázares, Heriberto, Prado-García, Angeles, Carlos-Reyes, José Sullivan, López-González
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 64(3)
Cells of the innate immune system are involved in discriminating between the innocuous cell death (apoptosis) which occurs in tissues during homeostasis, and the cell death associated to tissue damage (necrosis). Recently, a new variant of apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9cda90b9b5b34c6c9f35458da0c52743
https://pubmed.ncbi.nlm.nih.gov/23045951
https://pubmed.ncbi.nlm.nih.gov/23045951